List of Exelixis, Inc patents

List of Exelixis, Inc patents

List of AVG (company) patents

List of RGB SYSTEMS, INC. patents

List of Inventio patents

List of companies in SC Ventures's investment portfolio

List of funding rounds for Z LOAN & INVESTMENT INC

Patents where

Current Assignee

Name

is

Exelixis, Inc

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10501418 Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use	Patent 10501418 was granted and assigned to Exelixis, Inc on December, 2019 by the United States Patent and Trademark Office.	Exelixis	Exelixis, Inc		United States Patent and Trademark Office	10501418	December 10, 2019
	‌ US Patent 6852290 Multi-well apparatus	Patent 6852290 was granted and assigned to Exelixis, Inc on February, 2005 by the United States Patent and Trademark Office.		Exelixis, Inc		United States Patent and Trademark Office	6852290	February 8, 2005
	‌ US Patent 12016854 Liquid dosage forms to treat cancer	Patent 12016854 was granted and assigned to Exelixis, Inc on June, 2024 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	12016854	June 25, 2024
	‌ US Patent 10543206 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds	Patent 10543206 was granted and assigned to Exelixis, Inc on January, 2020 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	10543206	January 28, 2020
	‌ US Patent 10851061 Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use		Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	10851061	December 1, 2020
	‌ US Patent 10590102 Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone	Patent 10590102 was granted and assigned to Exelixis, Inc on March, 2020 by the United States Patent and Trademark Office.	Exelixis	Exelixis, Inc		United States Patent and Trademark Office	10590102	March 17, 2020
	‌ US Patent 10736886 Methods of using c-Met modulators	Patent 10736886 was granted and assigned to Exelixis, Inc on August, 2020 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	10736886	August 11, 2020
	‌ US Patent 7021294 Fuel pump control device	Patent 7021294 was granted and assigned to Exelixis, Inc on April, 2006 by the United States Patent and Trademark Office.		Exelixis, Inc		United States Patent and Trademark Office	7021294	April 4, 2006
	‌ US Patent 7049088 PRMTs as modifiers of the p53 pathway and methods of use	Patent 7049088 was granted and assigned to Exelixis, Inc on May, 2006 by the United States Patent and Trademark Office.		Exelixis, Inc		United States Patent and Trademark Office	7049088	May 23, 2006
	‌ US Patent 12017995 Crystalline forms and salt forms of a kinase inhibitor	Patent 12017995 was granted and assigned to Exelixis, Inc on June, 2024 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	12017995	June 25, 2024
	‌ US Patent 11969419 Method of treating cancer	Patent 11969419 was granted and assigned to Exelixis, Inc on April, 2024 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	11969419	April 30, 2024
	‌ US Patent 12128039 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds	Patent 12128039 was granted and assigned to Exelixis, Inc on October, 2024 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	12128039	October 29, 2024
	‌ US Patent 12084496 Anti-ROR antibody constructs	Patent 12084496 was granted and assigned to Exelixis, Inc on September, 2024 by the United States Patent and Trademark Office.	Exelixis, Inc	Exelixis, Inc		United States Patent and Trademark Office	12084496	September 10, 2024

13 results

0 selected

13 results

0 selected